Abstract
Anti-M antibodies are usually of IgM, appear as cold agglutinins and are clinically insignificant. We are reporting two cases of anti-M in cases of solid tumors where the anti-M caused discrepancy in blood grouping, reacted in coombs phase of crossmatching. Anti-M in first case showed dosage effect. These antibodies can be clinical significant when detected in coombs phase, making M antigen negative coombs compatible unit transfusion imperative.
Author supplied keywords
Cite
CITATION STYLE
Soni, S. K., Goyal, H., Sood, S. K., & Setia, R. (2014). Anti-M Antibody in Solid Tumors-Two Case Reports. Indian Journal of Hematology and Blood Transfusion, 30, 49–53. https://doi.org/10.1007/s12288-013-0243-6
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.